Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-27024

Xla Wt + slc16a2 CRISPR + L-T3 (5nM), Sterner ZR et al. (2023)

Experiment + Assay: Xla Wt + slc16a2 CRISPR + L-T3 (5nM) + NF54-55 (RT-PCR)
Background: Xla.J-strainNXR
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
CRISPR slc16a2 (Xla) slc16a2 (Xla)
 NF stage 1 whole organism
chemical liothyronine
NF stage 54 whole organism
Conditions:
Assay Type Assay Stages Antibody
RT-PCR NF stage 54 to NF stage 55  
Expression Phenotypes (4):
increased amount klf9.L expression in hindlimb
increased amount klf9.L expression in tail
increased amount thrb.L expression in hindlimb
increased amount thrb.L expression in tail
Source: Fig. 7 CD
Article: XB-ART-59481, PubMed